Sencohaven

Sencohaven
Sencohaven helps SENCOs manage EHCP reviews, provision maps, and actions in one place.
About
What does Sencohaven do?
Sencohaven offers a digital platform designed for efficient SEND (Special Educational Needs and Disabilities) management in schools. It centralizes EHCP reviews, provision maps, and actions, providing tools for digital meeting agendas, report generation, and an automatic audit trail. Sencohaven serves SENCOs by offering a comprehensive overview of student support and teachers by facilitating resource sharing and guided review processes.
Where is Sencohaven headquartered?
Sencohaven is headquartered in London, United Kingdom.
When was Sencohaven founded?
Sencohaven was founded in 2026.
What industry does Sencohaven operate in?
Sencohaven operates in EdTech, Vertical SaaS, Education Management, Workflow Automation, Compliance Software, Audit Trail.
AI-powered platform for personalized learning and skill development.
AI-powered platform for personalized learning and skill development.
Discover trading and investing the easy way. Finelo guides you with beginner-friendly lessons made for adults who are just getting started.
Um acompanha a convenção coletiva. O outro monta o evento do eSocial. Os dois existem pelo mesmo motivo: a obrigação que venceu antes de alguém ver.
Verify when a document was really written through forensic metadata analysis for educators.
AI-powered platform for personalized learning and skill development.
Aspirant League is an innovative educational platform where kids study with fun through engaging creative educational games and competitive learning.
We teach kids to see chess through adventures, not memorize it through lectures, using story-shaped puzzles with real chess rules.
An entrant is a company tagged EdTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 19 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
